Day: January 12, 2021

Capital Senior Living to Host Investor Meetings at Stifel Seniors Housing & Healthcare Real Estate Conference

DALLAS, Jan. 12, 2021 (GLOBE NEWSWIRE) — Capital Senior Living Corporation (the “Company” or “Capital Senior Living”) (NYSE: CSU), one of the nation’s leading senior living companies, announced today its management will host virtual investor meetings during Stifel’s Seniors Housing & Healthcare Real Estate Conference on Tuesday, January 19, 2021.President and Chief Executive Officer Kimberly S. Lody, Chief Operating Officer Brandon Ribar and Senior Vice President of Accounting and Finance Tiffany Dutton will be available for virtual meetings throughout the day. To arrange a meeting, investors should request an appointment through the conference portal. Additionally, Ribar will join the conference’s operator panel, “Making Sense Out of Chaos,” taking place Tuesday, January 19 from 1:00 to 1:45p.m. Central Time. Panelists include...

Continue reading

Pacific Biosciences Grants Equity Incentive Awards to New Employees

MENLO PARK, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality, long read sequencing platforms, today announced that the Board of Directors granted non-qualified stock options covering an aggregate of 750,000 shares of Pacific Biosciences common stock and restricted stock units (“RSUs”) covering 335,000 shares of Pacific Biosciences common stock to the Company’s recently hired Chief Operating Officer, Mark Van Oene, under the Pacific Biosciences 2020 Inducement Equity Incentive Plan (the “Inducement Plan”) effective on January 8, 2021.The Board of Directors also granted non-qualified stock options covering an aggregate of 320,000 shares of Pacific Biosciences common stock and RSUs covering 160,000 shares of Pacific...

Continue reading

Oncocyte to Present at the 23rd Annual Needham Virtual Growth Conference

IRVINE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (NYSE American: OCX), a molecular diagnostics company with a mission to provide actionable answers at critical decision points across the cancer care continuum, announced today that management is scheduled to present at the 23rd Annual Needham Virtual Growth Conference.Presentation details:Date: January 15, 2021Time: 10:45am ESTInvestors can register for the conference here: the conference, a webcast replay of the presentation will be available on the Investor section of the company’s website, Oncocyte CorporationOncocyte is a molecular diagnostics company whose mission is to provide actionable answers at critical decision points across the cancer care continuum. The Company, through its proprietary...

Continue reading

Roche confirms US government agreement to purchase additional doses of Regeneron’s casirivimab and imdevimab

New agreement covers 1.25 million additional doses of the antibody cocktail, bringing the total potential US supply to over 1.5 million dosesCasirivimab and imdevimab were granted U.S. FDA Emergency Use Authorization for recently-diagnosed, high-risk, mild to moderate COVID-19 patientsRoche and Regeneron are collaborating on developing and manufacturing casirivimab and imdevimab; Regeneron is distributing the antibody cocktail in the US and Roche will be responsible for distribution outside the USBasel, 12 January 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today confirmed that the U.S. Department of Health and Human Services (HHS) and the Department of Defense (DOD) will purchase additional supply of Regeneron’s casirivimab and imdevimab antibody cocktail for use in non-hospitalised COVID-19 patients as part of Operation Warp Speed....

Continue reading

Golden Leaf Holdings Provides Update Regarding Non-Brokered Private Placement including Management participation

NOT FOR RELEASE IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICESPORTLAND, Ore., Jan. 12, 2021 (GLOBE NEWSWIRE) — Golden Leaf Holdings Ltd. (CSE:GLH) (“Golden Leaf” or the “Company”), a premier, consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail, is pleased to announce that it has closed an initial tranche of its non-brokered private placement (the “Non-Brokered Offering”) of units (“Units”), previously announced on December 21, 2020, for gross proceeds of approximately C$2,375,000, including $190,500 from insiders. A total of 79,166,773 Units were issued at a purchase price of C$0.03 per Unit, with each Unit comprised of one common share of the Company (a “Common Share”) and one Common Share purchase warrant (a “Warrant”). Each Warrant is exercisable to acquire...

Continue reading

Northland Power to Host Virtual Investor Day

TORONTO, Jan. 12, 2021 (GLOBE NEWSWIRE) — Northland Power Inc. (“Northland“) (TSX: NPI) announces that it will host its 2021 virtual Investor Day on Thursday February 4, 2021 starting at 10:00 AM ET. Members of Northland’s executive leadership team will provide updates on the company’s achievements, long-term strategy and growth outlook as well as updates on Northland’s environmental, social, governance (ESG) initiatives, and its corporate and financial targets for 2021.The presentation will be broadcast live via webcast, with video and will be accessible by web browser. The presentation will be available on Northland’s website following the event.Webcast attendees can pre-register to receive the web access information. Attendees may also register on the day of the event.Event details:2021 Investor Day – Northland Power...

Continue reading

Predictive Oncology Announces Closing of $3.074 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

MINNEAPOLIS, Jan. 12, 2021 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the closing of its previously announced registered direct offering of 3,650,840 shares of its common stock, at a purchase price of $0.842 per share, which was priced at-the-market under Nasdaq rules. The gross proceeds to the Company from this offering were $3.074 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. In a concurrent private placement, the Company also issued to the same investors unregistered warrants to purchase up to an aggregate of 1,825,420 shares of common stock at an exercise price of $0.80 per...

Continue reading

Verus International Completes Requirements for Reverse Stock Split

Gaithersburg, MD, Jan. 12, 2021 (GLOBE NEWSWIRE) — Verus International, Inc. (“Verus” or the “Company”) (OTC Pink: VRUS) has completed its previously announced 1-for-500 reverse stock split.The Market Effective Date of the reverse stock split will be published by FINRA and can be accessed via FINRA’s Daily List for Over the Counter Equities. The Company has been advised that the Market Effective Date is January 13, 2021.Following the reverse stock split, Verus shares will be issued a new CUSIP number, and the share count will be reduced from a pre-split share count of 5,982,423,674 to a post-split share count of 11,964,847.The Company will send out a written communication to shareholders as of the record date of October 6, 2020 with additional details. For a reverse or forward split, a “D” will be placed on the ticker symbol for 20...

Continue reading

Tastemaker Acquisition Corp. Announces Closing of $276 Million Initial Public Offering

NEW YORK, Jan. 12, 2021 (GLOBE NEWSWIRE) — Tastemaker Acquisition Corp. (the “Company”), a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, today announced the closing of its initial public offering of 27,600,000 units, including 3,600,000 units issued to the underwriters upon full exercise of their over-allotment option, at a price of $10.00 per unit. The units began trading on The Nasdaq Capital Market (“Nasdaq”) on January 8, 2021 under the ticker symbol “TMKRU”.Each unit issued in the offering consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder to purchase one share of Class A...

Continue reading

Epiphany Technology Acquisition Corp. Announces Closing of $402,500,000 Initial Public Offering

New York, NY, Jan. 12, 2021 (GLOBE NEWSWIRE) — Epiphany Technology Acquisition Corp. (NASDAQ: EPHYU) (the “Company”) announced today that it closed its initial public offering of 40,250,000 units, including 5,250,000 units issued pursuant to the exercise by the underwriter of its over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $402,500,000.The Company’s units are listed on the Nasdaq Capital Market (“Nasdaq”) and commenced trading under the ticker symbol “EPHYU” on January 8, 2021. Each unit consists of one share of the Company’s Class A common stock and one-third of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Only whole warrants will trade and are exercisable.  Once the...

Continue reading

Disclaimer & Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.